Tell us what you think about Healio

  • News Wire Alerts
  • RSS Feeds
  • Hepatology

  • x

Loading...

  • Sign in for a personal experience.

    Customized content served to meet your interests.

  • All Specialties
  • Hepatology
  • Subspecialties
    • All Hepatology
    • Hepatitis C Resource Center
    • Autoimmune/Cholestatic/
      Biliary Diseases
    • Chronic Hepatitis
    • Cirrhosis/Liver Failure
    • Drug Metabolism/Pharmacology
    • Genetic Diseases
    • Immunology
    • Liver Injury/Regeneration
    • Oncology
    • Portal Hypertension
    • Practice Management
    • Steatohepatitis/Metabolic Liver Disease
    • Transplantation
    • Viral Hepatitis
  • All Specialties
  • Adolescent Medicine
  • Allergy/Immunology
  • Cardiology
  • Dermatology
  • Endocrinology
  • Gastroenterology
  • Geriatric Medicine
  • Health Professions
  • Hematology/Oncology
  • Hepatology
  • Infectious Disease
  • Nursing
  • Ophthalmology
  • Optometry
  • Orthopedics
  • Orthotics/Prosthetics
  • Pediatrics
  • Psychiatry
  • Rheumatology
  • Sports Medicine
  • News
    • All News
    • Meeting News Coverage
  • Video
  • Curbside Consultation
  • Books
  • Meetings
    • Meetings/Courses
    • Meeting News Coverage
  • Careers

Healio › Hepatology › News

  • Meeting News Coverage
  • Primary tumor resection as initial synchronous colorectal liver metastases therapy increased progression risk

  • HemOnc Today, June 10, 2013
  • Patients who undergo primary tumor resection as an initial treatment for synchronous colorectal liver metastases are at increased risk for progressive...More »
  • Meeting News Coverage Video
  • Fatty liver overlooked in minority patients with type 2 diabetes, obesity

  • May 3, 2013
  • PHOENIX — Kenneth Cusi, MD, FACP, FACE, warns physicians to consider fatty liver disease as a comorbidity in minority patients and children with...More »
  • Meeting News Coverage
  • Vitamin D deficiency linked to portal hypertension complications, poor prognosis among cirrhotic patients

  • May 3, 2013
  • Patients with alcoholic cirrhosis and severe vitamin D deficiency are at a greater risk for death and more likely to have severe cirrhosis and experience...More »
  • Meeting News Coverage
  • Weight loss through lifestyle changes, bariatric surgery improved NAFLD in obese patients

  • May 2, 2013
  • Obese patients who lose weight via lifestyle intervention or bariatric surgery experienced improvement to histological and metabolic elements of...More »
  • Meeting News Coverage
  • Beta-blockers reduced bacterial translocation, improved intestinal permeability in cirrhotic patients

  • May 1, 2013
  • Patients with cirrhosis treated with beta-blockers experienced improved intestinal permeability and reduced bacterial translocation, reducing the risk for...More »
  • Meeting News Coverage
  • Addition of simeprevir to peginterferon/ribavirin improves SVR rate among HCV patients

  • May 1, 2013
  • Simeprevir improves rates of sustained virologic response and may allow for a 24-week treatment duration when added to interferon-based therapy for...More »
  • Tolvaptan duration, usage limited due to possible liver injury

  • April 30, 2013
  • The FDA has determined that tolvaptan should not be used for longer than 30 days or in patients with underlying liver disease because it may cause liver...More »
  • Meeting News Coverage
  • Alcohol consumption, metabolic risk factors tied to cirrhosis, hepatocellular carcinoma

  • April 30, 2013
  • Heavy alcohol consumption and obesity increase the risk for liver-related morbidity and death, while metabolic risk factors also elevate the risk for...More »
  • Meeting News Coverage
  • Daclatasvir/asunaprevir/NS5B inhibitor effective in treatment-naive HCV patients

  • April 30, 2013
  • Treatment-naive patients with chronic hepatitis C experienced high rates of sustained virologic response from a combination of three direct-acting...More »
  • Meeting News Coverage
  • Probiotics may prevent hepatic encephalopathy among cirrhotic patients

  • April 29, 2013
  • Patients with cirrhosis were less likely to develop overt hepatic encephalopathy when taking probiotics than controls in a study presented at the...More »
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • Featured
  • Most Popular
  • In the Journals
  • High daily dose, lipophilicity indicate risk for drug-induced liver injury

  • June 18, 2013
  • Mindie Nguyen MD MAS on HCV demographics

  • May 24, 2013
  • Curbside Consultation
  • My Hospital Does Not Have an Endoscopic Ultrasonographer. Is It Safe for Me to Use Computed Tomography-Guided Fine Needle Aspiration for a Pancreatic Lesion?

  • Richard O’ Farrell, MD
  • In the Journals
  • High daily dose, lipophilicity indicate risk for drug-induced liver injury

  • June 18, 2013
  • GI Outlook 2013 Conference

  • August 9, 2013 - August 11, 2013
    Chicago,
  • APDW/WCOG Shanghai

  • September 21, 2013 - September 24, 2013
    Shanghai, China

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!



View past polls »

Advertisement
  • Resources from Industry
Account Information
  • Create New User
  • Login
  • Subscribe Or Buy
  • Update Publication Mailing Address
  • Help
Healio.com
  • About Healio
  • Publications
  • Editorial Board
  • Contact the News Desk
  • Contact Us
  • About the Wyanoke Group
  • Advertising Information
  • Reprints
  • Sitemap
Legal
  • Medical Disclaimer
  • Privacy Policy
  • Editorial Policy and Philosophy
  • Terms and Conditions
  • Permissions
Connect with Healio
  • Twitter
  • Facebook
  • RSS Feeds

©2013 All Rights Reserved.

position